EMD-18941

Single-particle
3.6 Å
EMD-18941
3D View Gallery
Deposition: 18/11/2023
Map released: 20/12/2023
Last modified: 20/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-18941

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 S (Spike) protein (BA.1) in complex with VHH Ma16B06 (sub-volume of two adjacent RBD-VHH modules)

EMD-18941

Single-particle
3.6 Å
EMD-18941
3D View Gallery
Deposition: 18/11/2023
Map released: 20/12/2023
Last modified: 20/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus, Vicugna pacos
Sample: SARS-CoV-2 S (Spike) protein (BA.1 variant) in complex with VHH Ma16B06 (sub-volume of two adjacent RBD-VHH modules)

Deposition Authors: Guttler T , Aksu M , Gorlich D
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters.
Aksu M , Kumar P , Guttler T , Taxer W, Gregor K , Mussil B, Rymarenko O, Stegmann KM, Dickmanns A, Gerber S, Reineking W , Schulz C, Henneck T, Mohamed A, Pohlmann G, Ramazanoglu M, Mese K, Gross U, Ben-Yedidia T, Ovadia O, Fischer DW, Kamensky M, Reichman A, Baumgartner W , von Kockritz-Blickwede M, Dobbelstein M, Gorlich D
(2023) Antiviral Res , 105778 - 105778
PUBMED: 38065245
DOI: doi:10.1016/j.antiviral.2023.105778
ISSN: 0166-3542
ASTM: ARSRDR
Grant Support: